Quantcast

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

uncertainty market evolution

Jefferies Contrarian Stocks to Buy: Arena, Rackspace and More

Posted: May 30, 2013 at 8:25 am

It is not unusual to see most research on Wall Street pretty much line up either for or against a company. Analysts typically look at the same metrics in the ...
Read Full Story »
Bull and Bear figures

Closing Bell for Thursday on Wall Street: Markets Rise to New Highs on Jobs Report

Posted: May 3, 2013 at 4:04 pm

U.S. equity markets opened higher this morning following upward revisions from the Bureau of Labor Statistics on non-farm payrolls in February and March and a larger-than-expected rise in payrolls in ...
Read Full Story »
pills

Arena Withdraws Application for Weight-Loss Drug Approval in Europe

Posted: May 3, 2013 at 8:30 am

Drug maker Arena Pharmaceuticals Inc. (NASDAQ: ARNA) has withdrawn its application for European regulatory approval of its weight-loss drug Belviq. The drug was approved for use in the United States ...
Read Full Story »
Bull and Bear figures

24/7 Wall St. Closing Bell — March 4, 2013: Markets Open Lower, Rise at End of Day (YHOO, NS, GPS, DF, MRK, ARNA, BYD, SSYS, RIG, YGE, CKP, CEP, FOE, SCSS, SSYS)

Posted: March 4, 2013 at 4:02 pm

U.S. equity markets opened lower this morning following news out of China that government is about to tighten restrictions on real estate transactions. The news pushed the Shanghai exchange down ...
Read Full Story »
Bull and Bear figures

24/7 Wall St. Closing Bell — March 1, 2013: Markets Struggle to Small Gains (DB, V, DRI, BUD, ADSK, BODY, CTIC, CLNE, DECK, GPS, MCP, PANW, SD, BBY, ARNA, BYD, SSYS, RIG, GRPN, MTG, IEP)

Posted: March 1, 2013 at 4:03 pm

U.S. equity markets opened lower this morning following a number of disappointing data releases in Europe and Asia. Eurozone PMI remains on the pessimistic side, with a reading of 47.9, ...
Read Full Story »
76764023

VIVUS Obesity Drug Sales Only About 60% of Expectations

Posted: February 25, 2013 at 5:08 pm

VIVUS Inc. (NASDAQ: VVUS) reported a quarterly loss of $0.56 per share on Monday, but this was not an earnings story. VIVUS remains a developing story about its obesity drug ...
Read Full Story »
76764023

Europe Denies Obesity Drug Approval

Posted: February 21, 2013 at 5:20 pm

If you are obese in Europe, you are not about to get a little pill to take to help you change. You will just have to lose that weight the old-fashioned ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades (ACI, ARNA, ADP, IRE, BOH, DELL, FHN, FSLR, FULT, GSS, HSY, INTU, ITRI, JCP, WFR, PNC, RF, SPWR, STP, TCB, USB, VIA, VVUS, WFC)

Posted: February 6, 2013 at 8:30 am

These are some of this Wednesday's top analyst upgrades, downgrades and initiations seen from Wall S. research calls. We have calls in banks, solar, tech, biotech and more. Arch Coal ...
Read Full Story »
76764023

Positive Clinical Study Could Provide a Tailwind for Obesity Drugs (VVUS, ARNA, OREX)

Posted: February 1, 2013 at 9:04 am

According to the Centers for Disease Control (CDC), more than one-third (35.7%) of all adults in the United States are obese or very overweight. Obesity-related medical conditions include heart attack, ...
Read Full Story »
Bull and Bear figures

24/7 Wall St. Closing Bell — January 22, 2013: Markets Shake Off Early Doldrums (TWC, SLB, DISH, ARMH, LNKD, DAL, FCX, JNJ, KSU, RF, VZ, AMD, CSX, GOOG, IBM, IGT, TXN, ABT, BHI, COH, GD, MCD, LCC, RIMM, DQ, LDK, ARNA)

Posted: January 22, 2013 at 4:04 pm

U.S. equity markets opened about flat this morning following the holiday weekend in the U.S. Foreign markets were also more or less mixed. In Europe, the German and eurozone economic ...
Read Full Story »
76764023

Arena Risk: Possible Drag on All Weight-Loss Drugs

Posted: January 22, 2013 at 1:21 pm

Arena Pharmaceuticals Inc. (NASDAQ: ARNA) is posing yet one more threat to ambitious biotechs and drug-makers who are targeting the obesity market. Its stock is getting slapped by almost 10% ...
Read Full Story »
76764023

The Obesity Drug Stock Rally Has Started (OREX, ARNA, VVUS, BAC)

Posted: January 16, 2013 at 8:16 am

Back in December, we took an in-depth look at what has become a crowded race in the obesity drug market. As we pointed out then, the race has become a ...
Read Full Story »
Cloud computing

Searching for Profits: Top Ticker Searches for 2012

Posted: December 31, 2012 at 1:05 pm

Some of the biggest business stories of the past year drew the most Internet search traffic to the newsmakers, which is really no big surprise. Whether just for curiosity or ...
Read Full Story »
76764023

Is There Finally a Winner in the Crowded Obesity Drug Market?

Posted: December 18, 2012 at 10:43 am

According to the Centers for Disease Control (CDC), more than one-third (35.7%) of all adults in the United States are obese. Obesity-related medical conditions include heart attack, stroke, type-2 diabetes ...
Read Full Story »

Short Interest in Biotech Remains Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

Posted: November 12, 2012 at 8:04 am

We have tracked the key short interest changes in the following biotech and emerging pharma companies: Alexion Pharmaceuticals Inc. (NASDAQ: ALXN), Amgen Inc. (NASDAQ: AMGN), Arena Pharmaceuticals Inc. (NASDAQ: ARNA), ...
Read Full Story »